Nasdaq-listed Hoth Therapeutics has announced plans to purchase Bitcoin as a treasury reserve asset. Hoth disclosed on Nov. 20 that its board of directors had approved the acquisition of $1 million worth of Bitcoin (BTC). The biopharmaceutical company will become…
Newsletter Signup
Subscribe to our weekly newsletter below and never miss the latest news.